Learn More
Medchemexpress LLC MedChemExpress KRAS G12D Inhibitor, Zoldonrasib, Potent, Orally Active, Solid

Supplier: Medchemexpress LLC HY1568192G
Zoldonrasib (RMC-9805) is a potent and orally active KRAS G12D inhibitor. It induces apoptosis in KRAS G12D mutant cancer cells and has potential for the research of KRAS G12D mutant cancer.
- Potent KRAS G12D inhibitor
- Orally active
- Induces apoptosis in KRAS G12D mutant cancer cells
- Potential for research of KRAS G12D mutant cancer
- Inhibits CXCL1 and GM-CSF production in eCT26 (KRASG12D/G12D) cells
- Shows antitumor activity in KRAS G12D xenograft models
- Decreases myeloid cells and increases cytotoxic T cells in mice
- Solid appearance
- White to yellow color
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.